Association between metabolic syndrome and risk of incident dementia in UK Biobank
- PMID: 37675869
- PMCID: PMC10916994
- DOI: 10.1002/alz.13439
Association between metabolic syndrome and risk of incident dementia in UK Biobank
Abstract
Introduction: The association between metabolic syndrome (MetS) and incident dementia remains inconclusive.
Methods: In 176,249 dementia-free UK Biobank participants aged ≥60 years at baseline, Cox proportional-hazards models were used to investigate the association between MetS and incident dementia. MetS was defined as the presence of ≥3 of the following: elevated waist circumference, triglycerides, blood pressure, blood glucose, and reduced high-density lipoprotein cholesterol.
Results: Over 15 years of follow-up (median = 12.3), 5255 participants developed dementia. MetS was associated with an increased risk of incident dementia (hazard ratio [HR]: 1.12, 95% confidence interval [CI]: 1.06, 1.18). The association remained consistent when restricting to longer follow-up intervals: >5 to 10 years (HR: 1.17, 95% CI: 1.07, 1.27) and >10 years (HR: 1.22, 95% CI: 1.12, 1.32). Stronger associations were observed in those with ≥4 MetS components and in apolipoprotein-E (APOE)-ε4 non-carriers.
Discussion: In this large population-based prospective cohort, MetS was associated with an increased risk of dementia.
Highlights: MetS was associated with a 12% increased risk of incident all-cause dementia. Associations remained similar after restricting the analysis to those with longer follow-up. The presence of four or five MetS components was significantly associated with dementia. Stronger associations were observed in those with a low genetic risk for dementia.
Keywords: UK biobank; cohort studies; dementia; follow-up studies; incidence; longitudinal; metabolic syndrome; risk factors.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



References
-
- Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640‐1645. - PubMed
-
- AH FEGWM . Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care. 2004;27:9. - PubMed
-
- Wong MC, Huang J, Pang TW, et al. Tu1007 worldwide incidence and prevalence of metabolic syndrome: a systematic review and meta‐analysis of 14.6 million individuals. Gastroenterology. 2020;158:S‐1003.
-
- Atti AR, Valente S, Iodice A, et al. Metabolic syndrome, mild cognitive impairment, and dementia: a meta‐analysis of longitudinal studies. Am J Geriatr Psychiatry. 2019;27:625‐637. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous